Public tenders for vaccination in Hungary

Find all Medical tenders in the world.
Finding business opportunities has never been easier.

Results for medical. Make a new search!

connection with the acquisition of HPV vaccination vaccine sales agreement

Országos Tisztifőorvosi Hivatal | Published March 23, 2017  -  Deadline April 20, 2017
cpvs
33651600

connection with the acquisition of HPV vaccination vaccine sales agreement

Purchase of vaccination against tick Public Employment Programme

Nyugat-dunántúli Vízügyi Igazgatóság | Published December 8, 2014
Winner
JUNIPERI Gyógyszertár Bt.
cpvs
33691300

Purchase of vaccination against tick-public employment programs. Vaccination against tick (FSME immune adults suspension for injection) 478 pcs

Rabies vaccination and supply of related services.

Nemzeti Élelmiszerlánc-biztonsági Hivatal | Published October 22, 2013
Winner
Hubertus Vadkereskedelmi Kft.Simon I. u. 29.Gödöllő 2100 hubertus@hubertus.com +36 28610975 +36 28610980
cpvs
85200000

Supply of anti-rabies vaccination and related services 6993 km ², a total of 139 860 doses of vaccine doses airplane outsourcing 20 / km ² density.

Purchase of oral vaccine against rabies, vaccination and care related services.

Nemzeti Élelmiszerlánc-biztonsági Hivatal | Published December 27, 2013  -  Deadline February 10, 2014
cpvs
85200000

Purchase of oral vaccine against rabies, vaccination and care related services.

Purchase supplies oral vaccine against rabies, vaccination and related services II. part

Nemzeti Élelmiszerlánc-biztonsági Hivatal | Published April 18, 2016
Winner
HUBERTUS Vadkereskedelmi Kft.
cpvs
85200000

Purchase supplies oral vaccine against rabies, vaccination and related services II. part

Information amending the contract - to provide the purchase of oral vaccine against rabies, vaccination and related services II. part

Nemzeti Élelmiszerlánc-biztonsági Hivatal | Published December 7, 2016
Winner
HUBERTUS Vadkereskedelmi Kft.
cpvs
85200000

Information amending the contract - to provide the purchase of oral vaccine against rabies, vaccination and related services II. part

Purchase orders and certain ancillary services related to the organization of vaccination (SG-751) against human papilloma virus (HPV) vaccine component 4.

Kecskemét Megyei Jogú Város Önkormányzata | Published July 20, 2013  -  Deadline September 2, 2013
cpvs
33651600

In order to obtain some additional services related to the organization of vaccination against human papilloma virus (HPV) four-component vaccine supply contract. Transportation contract draft detailed terms of the contract by the contracting authority as defined in the documentation.

Purchase orders and certain ancillary services related to the organization of vaccination (SG-751.) against the human papilloma virus (HPV) vaccine component 4

Kecskemét Megyei Jogú Város Önkormányzata | Published October 8, 2013
Winner
Hungaropharma Gyógyszerkereskedelmi Zrt.Király u. 12.Budapest 1061
cpvs
33651600

In order to obtain some additional services related to the organization of vaccination against human papilloma virus (HPV) four-component vaccine supply contract. Transportation contract draft detailed terms of the contract by the contracting authority as defined in the documentation.

Vaccines

Országos Tisztifőorvosi Hivatal | Published July 22, 2015
Winner
GlaxoSmithKline Kft.
cpvs
33651600, 33651680, 33651660

Purchase contract for the vaccine mandatory vaccination schedule procurement of year 2015.

Vaccination against ticks for a public work program of the West Pannon Directorate of Water (FSME-IMMUN adults, suspension for injection) purchase of 320 pieces

Nyugat-dunántúli Vízügyi Igazgatóság | Published November 20, 2015
Winner
Hermán Patika Kft.
cpvs
33651600

Vaccination against ticks for a public work program of the West Pannon Directorate of Water (FSME-IMMUN adults, suspension for injection) purchase of 320 pieces

Rabies vaccination and provision of related services

Nemzeti Élelmiszerlánc-biztonsági Hivatal | Published September 15, 2014
Winner
HUBERTUS Vadkereskedelmi Kft.
cpvs
85200000

Veszettség elleni vakcinázás és kapcsolódó szolgáltatások ellátása

Vaccines

Emberi Erőforrások Minisztériuma | Published November 14, 2017  -  Deadline December 14, 2017
cpvs
33651600, 33651620, 33651640

Contract for the purchase of vaccine for the vaccination system for the Ukraine - Subcarpathian region vaccine for the immunization program of children in Transcarpathia 2017-2021, 1670/2016. (XI.25.) Korm.

The extinguishing agents to be procured are to be used in Ukraine, Subcarpathian region, so it is necessary for them to comply with the Uruguayan Republic's vaccine marketing standards.

The Ukrainian party receiving the vaccine will take care of the extradition and release of vaccines from Ukraine to the Transcarpathia region.

Technical description:

Amount: 21 600 doses ATC code: J07CA06;

Purchase of oral vaccine against rabies, vaccination and related services supply

Nemzeti Élelmiszerlánc-biztonsági Hivatal | Published August 3, 2015  -  Deadline September 14, 2015
cpvs
85200000, 33651690

Veszettség elleni orális vakcina beszerzése, vakcinázás és kapcsolódó szolgáltatások ellátása

Vaccines

Országos Tisztifőorvosi Hivatal | Published March 22, 2017  -  Deadline April 20, 2017
cpvs
33651600

HPV vaccination vaccine within the framework of the purchase contract of sale.

contracting framework contract for the sale vaccine against human papilloma virus acquires.

Name of vaccines: against recombinant human papillomavirus, adsorbed, or recombinant adjuvanted vaccine or vaccine equivalent.

ATC code first 5 digits: J07B.

Packaging: pack offered by the supplier.

If the offered product packages ampoules, should be provided with the article for administration, offered by WHO type 2 syringes and needles.

Quality Requirements: The vaccine must comply with the WHO TRS 999: Recommendations to assure the Quality, safety and efficacy of recombinant virus-like particle Papilomavirus Human vaccines and the European Pharmacopoeia 07/2011: 2441 monograph.

Workability: The vaccine must be at least 24 months from supply to be used.

Total Amount: 120 000 doses of the basic amount and 138% option.

Discussion within the total quantity of raw and options can be varied, and on the basis of the negotiations, contracting assume any obligation to exercise the option expense of quantity.

Entry deadline:

01/08/2017 .: 45 000 doses, 11.02.2017 .: 15 000 doses, 06.01.2018 .: 45 000 doses, 11.02.2018 .: 15 000 doses.

The storage times may vary during the negotiations, base and option volume in the total quantity of change in storage further dates will be specified during the negotiations.

Marketing Authorisation:

The offered vaccine must have a marketing-authorization, as follows: should the offer be attached to the pharmaceutical administrative authority (Food and Drug Administration Food and Health Institute, that OGYE or previously Pharmaceutical Healthcare Quality and Development Institute, that GYEMSZI or former Food and Drug Administration Institute, that NIP) made or issued by the European Commission under Regulation 726/2004 / EC of the European Parliament and the Council, az1901 / 2006 / EC and Regulation 1394/2007 / EC of the European Parliament and of the Council of the European Parliament and of the Council of simple copy for marketing authorization of vaccines offered, where applicable, its translation.

Please note that the contracting OGYE check the website of the product for marketing authorization of the annexes to the existence and contents.

If the annexes to the marketing authorization electronically, Hungarian, full length, free OGYE not available on the website, please attach to these Hungarian translation.

Pharmaceutical wholesaler license: to be offered the vaccine -hozatali different marketing authorization holder for candidates invited to have a licensed pharmaceutical wholesaler, and the offer should enclose proof of distribution rights in Hungary, 53/2004. (VI.2.) No EszCsM and 2005 XCV. a simple copy of the pharmaceutical wholesaler license in accordance with the law.

Vaccines

Országos Tisztifőorvosi Hivatal | Published January 3, 2017  -  Deadline February 6, 2017
cpvs
33651600, 33651660, 33651670, 33651610

Five-component vaccine (combined, diphtheria, tetanus, acellular pertussis, inactivated polio and Haemophilus influenzae type b, primary vaccination and revaccination) within the framework of the purchase contract.

Purchase of the framework contract for the sale of five-component vaccine (combined, diphtheria, tetanus, acellular pertussis, Haemophilus influenzae type b and inactivated polio vaccine for primary immunization and booster doses.) ATC - Code: J07CA06.

Total Amount: 840 000 doses of the basic volumes + 50% option.

Discussion within the total quantity of raw and options can be varied, and on the basis of the negotiations, contracting assume any obligation to exercise the option expense of quantity.

Packaging: The transport offered by a single-dose formulations.

If the pre-filled syringes offered product, but needle-free packages, it must be accompanied by a performance of the contract when the vaccine matched, offered by the WHO type 2 needle.

If the offered product packages ampule must be accompanied by a performance of a contract for administration, offered by the WHO type 2 syringes and needles.

Quality requirements:

The extinguishing agent must comply with:

- WHO TRS 980: Recommendations to assure the quality, safety and efficacy of DT-based vaccines combined,

- WHO TRS 979: Recommendations to assure the quality, safety and efficacy of acellular pertussis vaccines,

- WHO TRS 897: Recommendations for the production and control of Haemophilus b conjugate vaccines influanzae type,

- WHO TRS 926: Recommendation for the safe production of inactivated poliomyelitis vaccine and qualitycontrol,

- WHO TRS 993: Recommendation to assure the quality, safety and efficacy of polio vaccines (inactivated)

- European Pharmacopoeia 07/2013: 2065 monograph requirements.

In case of default It is necessary to ensure the achievement of usability, regardless of the date of 18 months from the date specified by the contracting authority added.

Entry deadline:

The first entry date: 15 days after signing the contract: 100 000 doses.

06/01/2017 .: 100 000 doses.

08/01/2017 .: 100 000 doses.

11/02/2017 .: 100 000 doses.

02/01/2018 .: 120 000 doses.

05/02/2018 .: 120 000 doses.

08/01/2018 .: 100 000 doses.

11/02/2018 .: 100 000 doses.

The storage times may vary during the negotiations, base and option volume in the total quantity of change in storage further dates will be specified during the negotiations.

Marketing Authorisation:

The offered vaccine must have a marketing-authorization, as follows: should the offer be attached to the pharmaceutical administrative authority (Food and Drug Administration Food and Health Institute, that OGYE or previously Pharmaceutical Healthcare Quality and Development Institute, that GYEMSZI or former Food and Drug Administration Institute, that NIP) made or issued by the European Commission under Regulation 726/2004 / EC of the European Parliament and of the Council of the Regulation or of Regulation 1394/2007 / EC of the European Parliament and Council 1901/2006 / EC of the European Parliament and the Council, a simple copy of the market for the offered vaccine marketing authorization, if necessary by a translation.

Please note that the contracting OGYE check the website of the product for marketing authorization of the annexes to the existence and contents.

If the annexes to the marketing authorization electronically, Hungarian, full length, free OGYE not available on the website, please attach to these Hungarian translation.

"Sale and Purchase contract, forward sale and purchase of vaccines."

Országos Tisztifőorvosi Hivatal | Published September 2, 2014
Winner
Hungaropharma Gyógyszerkereskedemi Zrt.Király utca 12.Budapest 1061 andrasne.szabados@hungaropharma.hu +36 13276717 www.hungaropharma.hu+36 13276720
cpvs
33651600, 33651680, 33651520, 33651660, 33651610

Part 1: Human rabies vaccine (inactivated), serving 20,000 + 20% option. Part 2: Hepatitis A vaccine against adults for 10,000 + 20% option. Part 3: Hepatitis A vaccine against children and adolescents for 10 000 + 20% dose option. Part 4: for a recombinant hepatitis B vaccine in children against 2500 + 20% dose option. Part 5: 16% of human gamma-globulin 2000 dose of 20% is optional. Part 6: Human tetanus immunoglobulin against 300 + 20% option. Part 7: Influenza vaccine for infants dose 5000 + 20% option. Part 8: Diphtheria, tetanus and pertussis booster vaccination against adults and adolescents serving 23,000 + 20% option.

Veterinary services

Nemzeti Élelmiszerlánc – biztonsági Hivatal | Published October 13, 2015
Winner
Hubertus Vadkereskedelmi Kft.
cpvs
85200000, 33651690

Purchase of oral vaccine against rabies, vaccination and care related services.

Veterinary services

Nemzeti Élelmiszerlánc-biztonsági Hivatal | Published July 31, 2015  -  Deadline September 14, 2015
cpvs
85200000

Purchase of oral vaccine against rabies, vaccination and care related services.

Vaccines

Országos Tisztifőorvosi Hivatal | Published January 26, 2017  -  Deadline February 27, 2017
cpvs
33651600, 33651610, 33651680, 33651640

connection with the acquisition of vaccines, sales of 3 years (2017-2019). For years contract.

Combined sales agreement within the framework of contracting diphtheria, tetanus and pertussis vaccine acquires, adolescents and adults booster doses of the following conditions:

Quantity: 220 000 doses of the basic volumes + 50% option.

Discussion within the total quantity of raw and options can be varied, and the contracting assume any obligation to exercise the option expense amount based on the negotiations or the total quantity is optional.

ATC code: J07AJ52.

Packaging: pack offered by the supplier - in terms of primary packaging in a single dose - pack sizes.

If the pre-filled syringes offered product, but needle-free packages, the contract must be accompanied by the performance of the vaccine fitting offered by the WHO type 2 needle.

If the offered product must be accompanied ampoule packages, the contract has been made for administration, offered by the WHO type 2 syringes and needles.

Quality Requirements: The vaccine must comply with:

- WHO TRS 980: Recommendations to assure the quality, safety and efficacy of combined vaccines DT-based;

- WHO TRS 979: Recommendations to assure the quality, safety and efficacy of acellular pertussis vaccines;

- European Pharmacopoeia 07/2014: 2764 monograph requirements.

If the performance needed to ensure usability, regardless of the date for completion within 24 months from the date specified by the contracting authority added.

Entry deadline:

06/01/2017 .: 110 000 doses.

06/01/2018. 55 000 doses.

06/01/2019 .: 55 000 doses.

The storage times may vary during the negotiations, base and option volume in the total quantity of change in storage further dates will be specified during the negotiations.

During delivery of the vaccine given date, the total amount of overdue entry into the new place of delivery as appropriate.

During storage of the vaccine injection given due date, the total volume of traffic to be able to provide the contracting authority made available as appropriate.

Marketing Authorisation:

should the pharmaceutical administrative authority (Pharmacy and Food-Health Institute, that OGYE or previously Pharmaceutical Healthcare Quality and Development Institute, that GYEMSZI or earlier and Drug Administration, that NIP) The offered vaccines have or by the European Commission in 726 / 2004 / EC of the European Parliament and of the Council az1901 / 2006 / EC or issued pursuant to Regulation 1394/2007 / EC of the European Parliament and of the Council, entry on the offered vaccine marketing authorization, which is easy to copy, where appropriate, the European Parliament and of the Council It must be accompanied by a translation in the offer.

Please note that the contracting OGYE check the website of the product for marketing authorization of its annexes - Summary of Product Characteristics, package leaflet, labeling - the existence and contents.

If the annexes to the offered product for marketing authorization - Summary of Product Characteristics, package leaflet, labeling - in electronic form, the Hungarian language in their entirety, free of charge are not available in OGYE website, please attach to these Hungarian translation.

II.2.4) Description of the procurement:

within the framework of contracting hepatitis B vaccine purchase contract obtains, school vaccination campaign for the following conditions:

Quantity: 400 000 doses of the basic volumes + 65% option.

Discussion within the total quantity of raw and options can be varied, and the contracting assume any obligation to exercise the option debit the amount on the basis of the negotiations, or the total quantity is optional.

ATC code: J07BC01.

Packaging: offered by the supplier - in terms of primary packaging in a single dose - pack sizes.

If the pre-filled syringes offered product, but needle-free packages, the contract must be accompanied by the performance of the vaccine fitting offered by the WHO type 2 needle.

If the offered product must be accompanied packaged ampoule, the contracts the performance of the vaccine fitting offered by the WHO type 2 and 1 syringe needle.

Quality Requirements: The vaccine must meet the

Proposed replacement of: TRS 786, Annex 2 and TRS 889, Annex 4 (2010) and TRS 978;

- European Pharmacopoeia 07/2011: 1056 monograph requirements.

If the performance necessary to ensure the achievement of usability, regardless of the date of 30 months from the date specified by the contracting authority added.

Entry deadline: </

Vaccines

Országos Epidemiológiai Központ | Published August 13, 2015
Winner
GlaxoSmithKline Kft.
cpvs
33651600, 33651680, 33651640, 33651650, 33651610

Part 1: Tetanus vaccine: 400 doses + 20% option Part 2: Human rabies vaccine (inactivated): 400 + 20% dose option Part 3: Yellow fever vaccine: +20 1 300 doses section Option 4% Combined measles, mumps & rubella live virus vaccine + 400 + 20% dose option Part 5: Four-component meningococcal conjugate vaccine 12 months of age: 800 + 20% dose option Part 6: Recombinant hepatitis B vaccine for adults against 800 doses + 20% option Part 7: Combined Hepatitis A and B vaccine for adults against: 1,800 + 20% dose option Part 8: Hepatitis A vaccine for adults: 1000 + 20% dose option Part 9: polysaccharide vaccine against typhoid fever 2 years and older children and adults immunization: 2,000 + 20% dose option Part 10: Combined diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis (adsorbed) vaccine booster vaccination of adults: 1,300 + 20% dose option.